Johnson & Johnson

NYSE:JNJ

Market Cap

USD 360.41 B

Share Price

USD 149.79

Avg Daily Volume

9,317,871

Change (1 day)

-0.62%

Change (1 year)

1.36%

Change (YTD)

3.57%

Johnson & Johnson Dividend Yield on June 20, 2025: 3.31%

Johnson & Johnson Dividend Yield is 3.31% on June 20, 2025, a 0.79% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Johnson & Johnson 52-week low Dividend Yield is 3.42% on June 20, 2025, which is 3.26% above the current Dividend Yield.
  • Johnson & Johnson 52-week low Dividend Yield is 2.88% on June 20, 2025, which is -13.19% below the current Dividend Yield.
  • Johnson & Johnson average Dividend Yield for the last 52 weeks is 3.13%.
Key data
Date Dividend Yield Market Capitalization Share Price Share Price
Market news
Loading...
NYSE: JNJ

Johnson & Johnson

CEO Mr. Joaquin Duato
IPO Date Jan. 2, 1943
Location United States
Headquarters One Johnson & Johnson Plaza
Employees 138,100
Sector ๐Ÿฅ Health Care
Industries
Description

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Similar companies

GSK.L

GSK plc

USD 18.89

-2.25%

HLN.L

Haleon plc

USD 5.16

0.21%

600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.92

0.34%

000538.SZ

Yunnan Baiyao Group Co.,Ltd

USD 7.68

0.40%

4164.SR

Nahdi Medical Company

USD 33.42

2.10%

AJANTPHARM.NS

Ajanta Pharma Limited

USD 29.88

1.77%

4527.T

Rohto Pharmaceutical Co.,Ltd.

USD 14.08

-1.25%

4015.SR

Jamjoom Pharmaceuticals Factory Company

USD 41.62

1.02%

GXI.DE

Gerresheimer AG

USD 53.27

1.78%

600572.SS

Zhejiang CONBA Pharmaceutical Co.,Ltd.

USD 0.62

0.40%

LLY

Eli Lilly and Company

USD 762.73

-2.84%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

AZN.L

AstraZeneca PLC

USD 140.24

-1.30%

MRK

Merck & Co., Inc.

USD 79.06

-0.29%

AMGN

Amgen Inc.

USD 289.33

-0.10%

PFE

Pfizer Inc.

USD 23.97

0.38%

GILD

Gilead Sciences, Inc.

USD 108.50

0.46%

SAN.PA

Sanofi

USD 95.88

0.36%

BMY

Bristol-Myers Squibb Company

USD 46.86

0.04%

MCK

McKesson Corporation

USD 720.92

-1.10%

ELV

Elevance Health Inc.

USD 374.52

-0.37%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

COR

Cencora, Inc.

USD 293.66

-1.04%

REGN

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

LONN.SW

Lonza Group AG

USD 684.56

0.23%

L.TO

Loblaw Companies Limited

USD 161.81

-0.28%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

RKT.L

Reckitt Benckiser Group plc

USD 68.48

-0.44%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

USD 19.22

1.16%

4568.T

Daiichi Sankyo Company, Limited

USD 22.63

-2.53%

UCB.BR

UCB SA

USD 181.46

0.14%

4578.T

Otsuka Holdings Co., Ltd.

USD 47.94

-0.46%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.57

0.90%

DIVISLAB.NS

Divi's Laboratories Limited

USD 76.09

1.62%

TEVA.TA

Teva Pharmaceutical Industries Limited

USD 17.30

1.37%

INSM

Insmed Incorporated

USD 102.68

3.24%

6618.HK

JD Health International Inc.

USD 5.04

0.13%

WST

West Pharmaceutical Services, Inc.

USD 215.82

-0.98%

SMMT

Summit Therapeutics Inc.

USD 20.56

1.98%

CIPLA.NS

Cipla Limited

USD 17.31

1.15%

UTHR

United Therapeutics Corporation

USD 290.75

-0.33%

DRREDDY.NS

Dr. Reddy's Laboratories Limited

USD 15.30

0.03%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 36.56

0.20%

1177.HK

Sino Biopharmaceutical Limited

USD 0.64

2.89%

MANKIND.NS

Mankind Pharma Limited

USD 26.42

-1.47%

ZYDUSLIFE.NS

Zydus Lifesciences Limited

USD 11.05

0.84%

1093.HK

CSPC Pharmaceutical Group Limited

USD 0.97

0.13%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.00

-0.43%

StockViz Staff

June 22, 2025

Any question? Send us an email